Top

Osteoporosis International

Published in:

Open Access 01-11-2009 | Short Communication

Factors associated with diagnosis and treatment of osteoporosis in older adults

Authors: S. Nayak, M. S. Roberts, S. L. Greenspan

Published in: Osteoporosis International | Issue 11/2009

Abstract

Summary

Osteoporosis is often undiagnosed and untreated. We surveyed 1,830 adults and identified factors associated with osteoporosis diagnosis and treatment. Individuals with several risk factors, including older age, were not more likely to be diagnosed or treated. Measures should be taken to improve osteoporosis identification and treatment in high-risk patients.

Introduction

We aimed to identify patient characteristics associated with osteoporosis diagnosis and treatment.

Methods

Survey was mailed to 1,830 women and men ≥60 years old in Pennsylvania. Multivariable logistic regression analyses were performed to determine odds ratios for osteoporosis diagnosis and treatment for individuals with established osteoporosis risk factors.

Results

Surveys were completed by 1,268 adults (69.3%). Osteoporosis diagnosis was more commonly reported by participants with risk factors of female sex (OR, 3.60; 95% CI 2.31–5.61), prolonged oral steroid use (OR, 3.76, 95% CI 2.06–6.84), low-trauma fracture (OR, 2.14, 95% CI 1.44–3.17), height loss (OR, 1.83, 95% CI 1.28–2.64), and lower weight (OR, 1.35 per 11.4 kg decrease in weight; 95% CI, 1.16–1.56). Age and family history of osteoporosis were not predictive of osteoporosis diagnosis, when adjusting for other risk factors. Osteoporosis treatment was more commonly reported by participants with risk factors of female sex (OR, 5.19; 95% CI, 3.31–8.13), family history (OR, 2.18; 95% CI, 1.55–3.06), height loss (OR, 1.79; 95% CI 1.29–2.49), low-trauma fracture (OR, 1.66; 95% CI, 1.14–2.42), and lower weight (OR, 1.45 per 11.4 kg decrease in weight; 95% CI, 1.27–1.67). Osteoporosis treatment was not significantly associated with age or prolonged oral steroid use.

Conclusions

Individuals with several established osteoporosis risk factors are more likely to be underdiagnosed or undertreated.

U.S. Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General

Looker AC, Orwoll ES, Johnston CC Jr et al (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768CrossRef

Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed

Nelson HD, Helfand M, Woolf SH et al (2002) Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:529–541PubMed

Nguyen TV, Eisman JA, Kelly PJ et al (1996) Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 144:255–263PubMed

Huddleston JM, Whitford KJ (2001) Medical care of elderly patients with hip fractures. Mayo Clin Proc 76:295–298CrossRefPubMed

Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51:364–370CrossRefPubMed

Nevitt MC, Ettinger B, Black DM et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793–800PubMed

Oleksik A, Lips P, Dawson A et al (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384–1392CrossRefPubMed

10.

U.S. Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137:526–528

11.

The National Osteoporosis Foundation (NOF) (2008) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC

12.

Qaseem A, Snow V, Shekelle P et al (2008) Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148:680–684PubMed

13.

Kiebzak GM, Beinart GA, Perser K et al (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222CrossRefPubMed

14.

Morris CA, Cabral D, Cheng H et al (2004) Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med 19:783–790CrossRefPubMed

15.

Gehlbach SH, Fournier M, Bigelow C (2002) Recognition of osteoporosis by primary care physicians. Am J Public Health 92:271–273CrossRefPubMed

16.

Riggs BL, Melton LJ 3rd (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17:505S–511SCrossRefPubMed

17.

Siris ES, Miller PD, Barrett-Connor E et al (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822CrossRefPubMed

18.

Solomon DH, Brookhart MA, Gandhi TK et al (2004) Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 117:919–924CrossRefPubMed

19.

Kirk JK, Spangler JG, Celestino FS (2000) Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older. Pharmacotherapy 20:405–409CrossRefPubMed

20.

Freedman KB, Kaplan FS, Bilker WB et al (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A:1063–1070PubMed

21.

Yood RA, Harrold LR, Fish L et al (2001) Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med 161:1322–1327CrossRefPubMed

22.

Solomon DH, Katz JN, Jacobs JP et al (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46:3136–3142CrossRefPubMed

23.

Mudano A, Allison J, Hill J et al (2001) Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J Rheumatol 28:1298–1305PubMed

24.

Morris CA, Cheng H, Cabral D et al (2004) Predictors of screening and treatment of osteoporosis: a structural review of the literature. Endocrinologist 14:70–75CrossRef

25.

Curtis JR, Westfall AO, Allison JJ et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485–2494CrossRefPubMed

26.

Shah SK, Gecys GT (2006) Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect. J Am Osteopath Assoc 106:653–657PubMed

Title: Factors associated with diagnosis and treatment of osteoporosis in older adults
Authors: S. Nayak
M. S. Roberts
S. L. Greenspan
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 11/2009
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-008-0831-8

ACC 2024 Congress

Springer Medicine

Factors associated with diagnosis and treatment of osteoporosis in older adults

Abstract

Summary

Introduction

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2009

A call to action: developing and implementing a national action plan to improve bone health

Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis

The role of early life variables on the risk of fractures from birth to early adolescence: a prospective birth cohort study

Bilateral transient osteoporosis of the talus in pregnancy

Global vitamin D status and determinants of hypovitaminosis D